Common Contracts
4 similar Underwriting Agreement contracts by Applied Dna Sciences Inc, Alliance MMA, Inc., Milestone Scientific Inc.
●] Shares of Common Stock, [●] Pre-Funded Warrants to Purchase Shares of Common Stock [●] Common Warrants to Purchase Shares of Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 25th, 2019 • Applied Dna Sciences Inc • Services-miscellaneous business services
Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, (this “Agreement”), to sell to you, Maxim Group LLC (“Maxim” or the “Underwriter”), an aggregate of [●] shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), [●] pre-funded warrants (the “Pre-Funded Warrants”) with the right to purchase one share of Common Stock at an exercise price of $0.01 per share, and [●] common warrants (the “Common Warrants” and, together with the Pre-Funded Warrants, the “Warrants”) with the right to purchase one share of Common Stock at an exercise price of $[●]. The Common Stock and the Warrants are collectively referred to herein as the “Securities.” In addition, the Company proposes to grant to the Underwriter an option to purchase up to an additional [●] shares of Common Stock (the “Option Shares”) and/or up to an additional [●] Common Warrants (the “Option Warrants”) from the Company for the p
5,715,000 Shares of Common Stock and 1,428,750 Warrants to Purchase Shares of Common Stock MILESTONE SCIENTIFIC INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 1st, 2019 • Milestone Scientific Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Milestone Scientific Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, (this “Agreement”), to sell to you, Maxim Group LLC (“Maxim” or the “Underwriter”), an aggregate of 5,715,000 shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and 1,428,750 warrants (the “Warrants”) with the rights to purchase 0.25 of a share of Common Stock at an exercise price of $0.50 per share (together, “Securities”). In addition, the Company proposes to grant to the Underwriter an option to purchase up to an additional 857,250 shares of Common Stock (the “Option Shares”) and/or up to an additional 214,312 Warrants (the “Option Warrants”) from the Company for the purpose of covering over-allotments in connection with the sale of the Securities (collectively, the “Option Securities”). The Securities and the Option Securities are collectively referred to herein as the context requires as the “Transaction Securities.”
5,500,000 Shares of Common Stock and 5,500,000 Warrants to Purchase Shares of Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 21st, 2018 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
2,150,000 Shares of Common Stock and 1,935,000 Warrants ALLIANCE MMA, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 9th, 2018 • Alliance MMA, Inc. • Services-miscellaneous amusement & recreation • New York
